Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $114000.0.

  • CG Oncology's Other Non-Current Assets rose 11509.43% to $114000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $114000.0, marking a year-over-year increase of 11509.43%. This contributed to the annual value of $94000.0 for FY2024, which is 9798.59% down from last year.
  • Latest data reveals that CG Oncology reported Other Non-Current Assets of $114000.0 as of Q3 2025, which was up 11509.43% from $522000.0 recorded in Q2 2025.
  • CG Oncology's Other Non-Current Assets' 5-year high stood at $4.7 million during Q4 2023, with a 5-year trough of $53000.0 in Q1 2024.
  • For the 3-year period, CG Oncology's Other Non-Current Assets averaged around $759000.0, with its median value being $104000.0 (2024).
  • As far as peak fluctuations go, CG Oncology's Other Non-Current Assets tumbled by 9798.59% in 2024, and later soared by 88490.57% in 2025.
  • CG Oncology's Other Non-Current Assets (Quarter) stood at $4.7 million in 2023, then tumbled by 97.99% to $94000.0 in 2024, then increased by 21.28% to $114000.0 in 2025.
  • Its last three reported values are $114000.0 in Q3 2025, $522000.0 for Q2 2025, and $516000.0 during Q1 2025.